Reported 46,807 shares, down 155,834 (76.9%) from the prior quarter.
Reported value -88.2%; share count -76.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 203925 |
| 2024-06-30 | 281393 |
| 2024-09-30 | 871283 |
| 2024-12-31 | 857172 |
| 2025-03-31 | 101104 |
| 2025-06-30 | 142185 |
| 2025-09-30 | 245365 |
| 2025-12-31 | 1167343 |
| 2026-03-31 | 1543343 |
| 2026-06-30 | 1977666 |
| 2026-09-30 | 6663866 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 261,021 | +186,081 (248.3%) | < 0.01% | $6,663,866 | 2026-11-13 | |
| Q2 2026 | Added | 74,940 | +6,286 (9.2%) | < 0.01% | $1,977,666 | 2026-08-13 | |
| Q1 2026 | Added | 68,654 | +3,073 (4.7%) | < 0.01% | $1,543,343 | 2026-05-15 | |
| Q4 2025 | Added | 65,581 | +4,545 (7.4%) | < 0.01% | $1,167,343 | 2026-02-13 | |
| Q3 2025 | Reduced | 61,036 | -3,594 (-5.6%) | < 0.01% | $245,365 | 2025-11-14 | |
| Q2 2025 | Added | 64,630 | +17,823 (38.1%) | < 0.01% | $142,185 | 2025-08-15 | |
| Q1 2025 | Reduced | 46,807 | -155,834 (-76.9%) | < 0.01% | $101,104 | 2025-05-15 | |
| Q4 2024 | Added | 202,641 | +126,480 (166.1%) | < 0.01% | $857,172 | 2025-02-14 | |
| Q3 2024 | Added | 76,161 | +49,838 (189.3%) | < 0.01% | $871,283 | 2024-11-14 | |
| Q2 2024 | Added | 26,323 | +13,038 (98.1%) | < 0.01% | $281,393 | 2024-08-14 | |
| Q1 2024 | New | 13,285 | +13,285 (0.0%) | < 0.01% | $203,925 | 2024-05-15 |
Who else reported the position
95 managers reported ALTO NEUROSCIENCE INC for Q1 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Alpha Wave Global LP | Unchanged | 3,707,757 | 0 | 3.57% | $8,008,755 | 5 qtrs |
| ARMISTICE CAPITAL LLC | Added | 1,600,000 | +950,000 | 0.05% | $3,456,000 | 2 qtrs |
| BlackRock Inc | Reduced | 1,459,176 | -20,838 | < 0.01% | $3,151,820 | 3 qtrs |
| FMR LLC | Added | 1,272,686 | +7,140 | < 0.01% | $2,749,002 | 5 qtrs |
| Point72 Asset Management L P | Reduced | 1,240,053 | -452,100 | < 0.01% | $2,678,514 | 5 qtrs |
| VANGUARD GROUP INC | Reduced | 1,218,645 | -11,022 | < 0.01% | $2,632,273 | 5 qtrs |
| FRANKLIN RESOURCES INC | Unchanged | 1,162,608 | 0 | < 0.01% | $2,511,233 | 5 qtrs |
| Vestal Point Capital LP | Unchanged | 915,000 | 0 | 0.14% | $1,976,400 | 5 qtrs |
| AWM Investment Company Inc | Added | 901,984 | +214,153 | 0.27% | $1,948,285 | 5 qtrs |
| MARSHALL WACE LLP | Added | 852,990 | +15,616 | < 0.01% | $1,842,457 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2025
- Filed
- May 15, 2025
- Filing type
- 13F-HR
- Position type
- COM SHS
Voting authority reported
- Sole
- 45,689
- Shared
- 0
- None
- 1,118
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.